Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Cost of RevenueLeasesLong-Term Debt IssuancesOther Gross PP&E AdjustmentsReceivables - Net
Ratios

Guided Therapeutics (GTHP) Accumulated Depreciation & Amortization (2019 - 2020)

Guided Therapeutics (GTHP) has disclosed Accumulated Depreciation & Amortization for 2 consecutive years, with $1.7 million as the latest value for Q4 2020.

  • Quarterly Accumulated Depreciation & Amortization fell 27.04% to $1.7 million in Q4 2020 from the year-ago period, while the trailing twelve-month figure was $1.7 million through Dec 2020, down 27.04% year-over-year, with the annual reading at $1.7 million for FY2020, 27.04% down from the prior year.
  • Accumulated Depreciation & Amortization hit $1.7 million in Q4 2020 for Guided Therapeutics, down from $2.4 million in the prior quarter.
  • In the past five years, Accumulated Depreciation & Amortization ranged from a high of $2.4 million in Q4 2019 to a low of $1.7 million in Q4 2020.